These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2717572)

  • 1. [Effect of merkazolyl on the level of thyrostimulating immunoglobulins of the blood in patients with diffuse toxic goiter].
    Oleĭnik VA; Khalangot ND
    Probl Endokrinol (Mosk); 1989; 35(1):32-5. PubMed ID: 2717572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dynamics of thyrostimulating immunoglobulin levels during treatment of diffuse toxic goiter].
    Sviridenko NIu; Mkrtukova NA; Kraĭnova SI; Nefedov SB; Kandror VI
    Probl Endokrinol (Mosk); 1991; 37(1):15-7. PubMed ID: 1674150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of mercasolyl on immunologic indicators in patients with diffuse toxic goiter].
    Epishin AV; Solomko LD; Epishina NA; Kuz'mich IuP
    Vrach Delo; 1989 Feb; (2):11-4. PubMed ID: 2711649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experience using lithium carbonate in the complex treatment of diffuse toxic goiter].
    Petrov NM
    Ter Arkh; 1985; 57(12):32-6. PubMed ID: 3937256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Substrate metabolism in untreated and treated thyrotoxicosis].
    Møller N; Hove KY; Nielsen S; Nyholm B; Pørksen NK; Weeke J
    Ugeskr Laeger; 1998 Mar; 160(10):1475-9. PubMed ID: 9520616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dynamics of interleukin 2 production in patients with diffuse toxic goiter under the influence of treatment].
    Shatsova EN; Malaitsev VV; Bogdanova IM
    Probl Endokrinol (Mosk); 1988; 34(6):24-6. PubMed ID: 2976937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibodies to the plasma membranes of thyrocytes in patients with diffuse toxic goiter during treatment with mercazole].
    Saarma VA; Podar TU
    Probl Endokrinol (Mosk); 1988; 34(5):17-9. PubMed ID: 3217382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Predicting the recurrence of thyrotoxicosis after iodine radioisotope therapy of diffuse toxic goiter].
    Ametov AS; Livshits AKh; Oleĭnik EK
    Probl Endokrinol (Mosk); 1988; 34(1):13-6. PubMed ID: 3362805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of thyroid hormones on calcitonin secretion].
    Rom-Bugoslavskaia ES; Gopkalova IV
    Probl Endokrinol (Mosk); 1988; 34(6):9-13. PubMed ID: 3237673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Several aspects of the pathogenesis of disturbances of hemostasis in patients with diffuse toxic goiter].
    Oleĭnik VA; Matiashina GI
    Ter Arkh; 1988; 60(9):43-6. PubMed ID: 3217879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [State of the renin-angiotensin-aldosterone system in thyroid pathology based on the results of radioimmunoassay].
    Matveenko EG; Gorobets VF; Dustov AD
    Ter Arkh; 1987; 59(11):41-4. PubMed ID: 2831633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease.
    Rittmaster RS; Zwicker H; Abbott EC; Douglas R; Givner ML; Gupta MK; Lehmann L; Reddy S; Salisbury SR; Shlossberg AH; Tan MH; York SE
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3283-8. PubMed ID: 8784084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunological characteristics of patients with diffuse toxic goiter].
    Sekhniashvili ZSh
    Probl Endokrinol (Mosk); 1988; 34(2):3-5. PubMed ID: 2969106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of thyroid-stimulating immunoglobulins and thyrotropin-releasing hormone responsiveness in women with euthyroid goiter.
    Smyth PP; Neylan D; O'Donovan DK
    J Clin Endocrinol Metab; 1983 Nov; 57(5):1001-6. PubMed ID: 6137491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in the immune status indices of patients with diffuse toxic goiter in different stages of the disease].
    Livshits AKh; Oleĭnik EK
    Probl Endokrinol (Mosk); 1985; 31(6):6-10. PubMed ID: 3841395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Triiodothyronine thyrotoxicosis in nodular toxic goiter].
    Raskin AM; Alesov VZ; Lebedeva NA; Shlimovich PB
    Probl Endokrinol (Mosk); 1976; 22(3):30-3. PubMed ID: 59358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study.
    Bartalena L; Brogioni S; Grasso L; Bogazzi F; Burelli A; Martino E
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2930-3. PubMed ID: 8768854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similar effects of thionamide drugs and perchlorate on thyroid-stimulating immunoglobulins in Graves' disease: evidence against an immunosuppressive action of thionamide drugs.
    Wenzel KW; Lente JR
    J Clin Endocrinol Metab; 1984 Jan; 58(1):62-9. PubMed ID: 6196375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy.
    Lytton SD; Ponto KA; Kanitz M; Matheis N; Kohn LD; Kahaly GJ
    J Clin Endocrinol Metab; 2010 May; 95(5):2123-31. PubMed ID: 20237164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevance of thyroid-stimulating immunoglobulins in graves' ophthalmopathy.
    Ponto KA; Kanitz M; Olivo PD; Pitz S; Pfeiffer N; Kahaly GJ
    Ophthalmology; 2011 Nov; 118(11):2279-85. PubMed ID: 21684605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.